High multiple births due to fertility treatments: Study

Image
IANS Washington
Last Updated : Dec 05 2013 | 12:16 PM IST

More than a third of twin births and more than three-quarters of triplets or higher-order births in the US are the result of assisted reproductive technologies, a new finding says.

The researchers from Brown University gathered data on multiple births from 1962 to 1966 before any medical fertility treatments were available and from 1971 through 2011, when data on in vitro fertilization (IVF) procedures were available.

They found that the contribution of fertility treatments over the past 40 years is clear: Between 1971 and 2011, the proportion of US multiple births rose to 3.5 percent from 1.8 percent.

Even after adjusting for maternal age, the rate of twin births rose 1.6 times between 1971 and 2009, Xinhua quoted the researchers as saying.

However, the proportion of triplets or more related to fertility treatments has actually dropped from a peak of 84 percent in 1998 after IVF guidelines discouraging implantation of three or more embryos took effect that year, researchers at Brown University said Wednesday.

Some mothers and couples may hope for twins through fertility treatments, but more often multiple births are not desired, said senior author Eli Adashi, professor of obstetrics and gynecology at Brown University.

"We do have a real problem with way too many multiple births in the US with consequences to both mothers and babies," Adashi said in a statement.

While multiple births from IVF are a direct result of the number of embryos that are fertilized and intentionally implanted, non-IVF therapies involve medications that stimulate ovulation and follicle growth in ways that cannot be precisely predicted or controlled, the researchers said.

"IVF is moving, in a sense, in the right direction and cleaning up its act, whereas the non-IVF technologies are at a minimum holding their own and possibly getting worse," Adashi said.

"From a policy point of view what that means is that (we) need to focus on the non-IVF technologies, which really hasn't been done in a concerted way because they weren't considered all that relevant to this mix."

The findings were published in the US journal New England Journal of Medicine.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 05 2013 | 12:14 PM IST

Next Story